Johnson & Johnson stock rout: What's driving the sharp decline? - J&J stock slides despite higher earnings guidance
· economictimes.indiatimes.com
Johnson & Johnson shares fell sharply on October 13, with losses reaching about 6.8% during intraday trading, despite the healthcare giant raising its full-year earnings outlook. Investors focused on weak reported profits and uneven performance across its business segments. (Source: GuruFocus, Investing.com) J&J stock slides despite higher earnings guidance
J&J’s quarterly sales rose 5.9% to $25.4 billion, but lower adjusted earnings, MedTech weakness and litigation-related charges overshadowed the revenue growth...